These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16188503)

  • 1. Recent advances in gastric ulcer therapeutics.
    Wallace JL
    Curr Opin Pharmacol; 2005 Dec; 5(6):573-7. PubMed ID: 16188503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAID-induced gastric injury: its pathogenesis and management.
    Earnest DL
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 2):6-10. PubMed ID: 2181675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori and NSAID.
    Wu CY; Wu MS; Chen YJ; Chen CJ; Lin JT; Chen GH
    Hepatogastroenterology; 2006; 53(71):797-803. PubMed ID: 17086892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
    Wallace JL
    Physiol Rev; 2008 Oct; 88(4):1547-65. PubMed ID: 18923189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa.
    Takeuchi K; Tanaka A; Kato S; Aihara E; Amagase K
    J Pharmacol Exp Ther; 2007 Sep; 322(3):903-12. PubMed ID: 17578900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of heat shock protein 27 in gastric mucosal injury.
    Ebert MP; Schäfer C; Chen J; Hoffmann J; Gu P; Kubisch C; Carl-McGrath S; Treiber G; Malfertheiner P; Röcken C
    J Pathol; 2005 Oct; 207(2):177-84. PubMed ID: 16041694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
    Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins.
    Heeba GH; Hassan MK; Amin RS
    Eur J Pharmacol; 2009 Apr; 607(1-3):188-93. PubMed ID: 19217901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxins in gastric mucosal health and disease.
    Wallace JL; de Lima OM; Fiorucci S
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):251-5. PubMed ID: 16024242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guideline for prophylaxis and treatment of NSAID-associated gastric ulcerations].
    Hiraishi H; Yamagata M; Yoneda M; Shimada T
    Nihon Rinsho; 2007 Oct; 65(10):1812-7. PubMed ID: 17926529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.